BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 15959843)

  • 1. Brain perfusion SPECT in patients with mild cognitive impairment and Alzheimer's disease: comparison of a semiquantitative and a visual evaluation.
    Staffen W; Schönauer U; Zauner H; Spindler I; Mair A; Iglseder B; Bernroider G; Ladurner G
    J Neural Transm (Vienna); 2006 Feb; 113(2):195-203. PubMed ID: 15959843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study.
    Nobili F; Frisoni GB; Portet F; Verhey F; Rodriguez G; Caroli A; Touchon J; Calvini P; Morbelli S; De Carli F; Guerra UP; Van de Pol LA; Visser PJ
    J Neurol; 2008 Sep; 255(9):1344-53. PubMed ID: 18958573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semi-quantitative analysis of perfusion of Brodmann areas in the differential diagnosis of cognitive impairment in Alzheimer's disease, fronto-temporal dementia and mild cognitive impairment.
    Tranfaglia C; Palumbo B; Siepi D; Sinzinger H; Parnetti L
    Hell J Nucl Med; 2009; 12(2):110-4. PubMed ID: 19675861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral perfusion (HMPAO-SPECT) in patients with depression with cognitive impairment versus those with mild cognitive impairment and dementia of Alzheimer's type: a semiquantitative and automated evaluation.
    Staffen W; Bergmann J; Schönauer U; Zauner H; Kronbichler M; Golaszewski S; Ladurner G
    Eur J Nucl Med Mol Imaging; 2009 May; 36(5):801-10. PubMed ID: 19137294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease.
    Encinas M; De Juan R; Marcos A; Gil P; Barabash A; Fernández C; De Ugarte C; Cabranes JA
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1473-80. PubMed ID: 14579086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cerebral SPECT and neuropsychological function in Alzheimer's disease].
    Arbizu J; Larumbe R; Rubio L; Villas A; Martínez-Lage JM; Richter JA
    Rev Med Univ Navarra; 1997; 41(1):12-8. PubMed ID: 9527710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative use of SPECT in frontal lobe-type dementia versus (senile) dementia of the Alzheimer's type.
    Pickut BA; Saerens J; Mariën P; Borggreve F; Goeman J; Vandevivere J; Vervaet A; Dierckx R; de Deyn PP
    J Nucl Med; 1997 Jun; 38(6):929-34. PubMed ID: 9189144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
    Ito K; Shimano Y; Imabayashi E; Nakata Y; Omachi Y; Sato N; Arima K; Matsuda H
    Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain perfusion correlates of visuoperceptual deficits in mild cognitive impairment and mild Alzheimer's disease.
    Alegret M; Vinyes-Junqué G; Boada M; Martínez-Lage P; Cuberas G; Espinosa A; Roca I; Hernández I; Valero S; Rosende-Roca M; Mauleón A; Becker And JT; Tárraga L
    J Alzheimers Dis; 2010; 21(2):557-67. PubMed ID: 20555146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evidence of Alzheimer changes in progressive mild cognitive impairment: a qualitative and quantitative SPECT study.
    Ishiwata A; Sakayori O; Minoshima S; Mizumura S; Kitamura S; Katayama Y
    Acta Neurol Scand; 2006 Aug; 114(2):91-6. PubMed ID: 16867030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment.
    Habert MO; Horn JF; Sarazin M; Lotterie JA; Puel M; Onen F; Zanca M; Portet F; Touchon J; Verny M; Mahieux F; Giron A; Fertil B; Dubois B
    Neurobiol Aging; 2011 Jan; 32(1):15-23. PubMed ID: 19250707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease.
    Nobili F; Brugnolo A; Calvini P; Copello F; De Leo C; Girtler N; Morbelli S; Piccardo A; Vitali P; Rodriguez G
    Clin Neurophysiol; 2005 Feb; 116(2):364-75. PubMed ID: 15661114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (99m)Tc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer disease.
    Devanand DP; Van Heertum RL; Kegeles LS; Liu X; Jin ZH; Pradhaban G; Rusinek H; Pratap M; Pelton GH; Prohovnik I; Stern Y; Mann JJ; Parsey R
    Am J Geriatr Psychiatry; 2010 Nov; 18(11):959-72. PubMed ID: 20808143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional cerebral blood flow deficits in mild Alzheimer's disease using high resolution single photon emission computerized tomography.
    Trollor JN; Sachdev PS; Haindl W; Brodaty H; Wen W; Walker BM
    Psychiatry Clin Neurosci; 2005 Jun; 59(3):280-90. PubMed ID: 15896221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMPAO-SPECT Can Discriminate between Patients with Subjective Cognitive Complaints with and without Cognitive Deficits and those with Mild Cognitive Impairment.
    Rossini F; Zauner H; Bergmann J; Kronbichler M; Spindler I; Golaszewski S; Trinka E; Staffen W
    Curr Alzheimer Res; 2019; 16(9):843-851. PubMed ID: 31453786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
    Johnson NA; Jahng GH; Weiner MW; Miller BL; Chui HC; Jagust WJ; Gorno-Tempini ML; Schuff N
    Radiology; 2005 Mar; 234(3):851-9. PubMed ID: 15734937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A region-of-interest template for three-dimensional stereotactic surface projection images: initial application to the analysis of Alzheimer's disease and mild cognitive impairment.
    Kubota T; Ushijima Y; Okuyama C; Nishimura T
    Nucl Med Commun; 2006 Jan; 27(1):37-44. PubMed ID: 16340722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional Cerebral Blood Flow in [123]I-IMP Single-photon Emission Computed Tomography and the Wechsler Memory Scale-revised in Nondemented Elderly Subjects with Subjective Cognitive Impairment.
    Niwa F; Kondo M; Sakurada K; Nakagawa M; Imanishi J; Mizuno T
    Intern Med; 2016; 55(24):3571-3578. PubMed ID: 27980255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT.
    Hirao K; Ohnishi T; Hirata Y; Yamashita F; Mori T; Moriguchi Y; Matsuda H; Nemoto K; Imabayashi E; Yamada M; Iwamoto T; Arima K; Asada T
    Neuroimage; 2005 Dec; 28(4):1014-21. PubMed ID: 16129627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.